BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 30017961)

  • 1. Disease-directed design of biodegradable polymers: Reactive oxygen species and pH-responsive micellar nanoparticles for anticancer drug delivery.
    Leong J; Chin W; Ke X; Gao S; Kong H; Hedrick JL; Yang YY
    Nanomedicine; 2018 Nov; 14(8):2666-2677. PubMed ID: 30017961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymeric nanoparticles responsive to intracellular ROS for anticancer drug delivery.
    Xu L; Zhao M; Gao W; Yang Y; Zhang J; Pu Y; He B
    Colloids Surf B Biointerfaces; 2019 Sep; 181():252-260. PubMed ID: 31153020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual pH-Responsive Shell-Cleavable Polycarbonate Micellar Nanoparticles for in Vivo Anticancer Drug Delivery.
    Liu S; Ono RJ; Yang C; Gao S; Ming Tan JY; Hedrick JL; Yang YY
    ACS Appl Mater Interfaces; 2018 Jun; 10(23):19355-19364. PubMed ID: 29757607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation of polyethylene glycol-polyacrylic acid block copolymer micelles with pH/hypoxic dual-responsive for tumor chemoradiotherapy.
    Weng J; Huang Z; Pu X; Chen X; Yin G; Tian Y; Song Y
    Colloids Surf B Biointerfaces; 2020 Jul; 191():110943. PubMed ID: 32203861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzymatic multifunctional biodegradable polymers for pH- and ROS-responsive anticancer drug delivery.
    Su M; Xiao S; Shu M; Lu Y; Zeng Q; Xie J; Jiang Z; Liu J
    Colloids Surf B Biointerfaces; 2020 Sep; 193():111067. PubMed ID: 32388121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. pH-triggered charge-reversal and redox-sensitive drug-release polymer micelles codeliver doxorubicin and triptolide for prostate tumor therapy.
    Xu C; Song RJ; Lu P; Chen JC; Zhou YQ; Shen G; Jiang MJ; Zhang W
    Int J Nanomedicine; 2018; 13():7229-7249. PubMed ID: 30510415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bicomponent polymeric micelles for pH-controlled delivery of doxorubicin.
    Wang C; Qi P; Lu Y; Liu L; Zhang Y; Sheng Q; Wang T; Zhang M; Wang R; Song S
    Drug Deliv; 2020 Dec; 27(1):344-357. PubMed ID: 32090637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of non-covalent interactions in anticancer drug loading and kinetic stability of polymeric micelles.
    Yang C; Attia AB; Tan JP; Ke X; Gao S; Hedrick JL; Yang YY
    Biomaterials; 2012 Apr; 33(10):2971-9. PubMed ID: 22244697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. cRGD-functionalized reduction-sensitive shell-sheddable biodegradable micelles mediate enhanced doxorubicin delivery to human glioma xenografts in vivo.
    Zhu Y; Zhang J; Meng F; Deng C; Cheng R; Feijen J; Zhong Z
    J Control Release; 2016 Jul; 233():29-38. PubMed ID: 27178807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of novel polymeric micellar drug conjugates and nano-containers with hydrolyzable core structure for doxorubicin delivery.
    Mahmud A; Xiong XB; Lavasanifar A
    Eur J Pharm Biopharm; 2008 Aug; 69(3):923-34. PubMed ID: 18430550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cationic drug-based self-assembled polyelectrolyte complex micelles: Physicochemical, pharmacokinetic, and anticancer activity analysis.
    Ramasamy T; Poudel BK; Ruttala H; Choi JY; Hieu TD; Umadevi K; Youn YS; Choi HG; Yong CS; Kim JO
    Colloids Surf B Biointerfaces; 2016 Oct; 146():152-60. PubMed ID: 27318960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multifunctional hybrid micelles with tunable active targeting and acid/phosphatase-stimulated drug release for enhanced tumor suppression.
    Liu X; Li Y; Tan X; Rao R; Ren Y; Liu L; Yang X; Liu W
    Biomaterials; 2018 Mar; 157():136-148. PubMed ID: 29268144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bile Acid-Based Drug Delivery Systems for Enhanced Doxorubicin Encapsulation: Comparing Hydrophobic and Ionic Interactions in Drug Loading and Release.
    Cunningham AJ; Robinson M; Banquy X; Leblond J; Zhu XX
    Mol Pharm; 2018 Mar; 15(3):1266-1276. PubMed ID: 29378128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-directing star-shaped block copolymers: supramolecular vesicles for the delivery of anticancer drugs.
    Yang C; Liu SQ; Venkataraman S; Gao SJ; Ke X; Chia XT; Hedrick JL; Yang YY
    J Control Release; 2015 Jun; 208():93-105. PubMed ID: 25813888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thermo- and pH dual responsive polymeric micelles and nanoparticles.
    Kalhapure RS; Renukuntla J
    Chem Biol Interact; 2018 Nov; 295():20-37. PubMed ID: 30036501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted Delivery of Doxorubicin via CD147-Mediated ROS/pH Dual-Sensitive Nanomicelles for the Efficient Therapy of Hepatocellular Carcinoma.
    Qu C; Li J; Zhou Y; Yang S; Chen W; Li F; You B; Liu Y; Zhang X
    AAPS J; 2018 Feb; 20(2):34. PubMed ID: 29476273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PEG-b-poly (carbonate)-derived nanocarrier platform with pH-responsive properties for pancreatic cancer combination therapy.
    Ray P; Confeld M; Borowicz P; Wang T; Mallik S; Quadir M
    Colloids Surf B Biointerfaces; 2019 Feb; 174():126-135. PubMed ID: 30447521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzyme-Triggered Disassembly of Polymeric Micelles by Controlled Depolymerization via Cascade Cyclization for Anticancer Drug Delivery.
    Park J; Jo S; Lee YM; Saravanakumar G; Lee J; Park D; Kim WJ
    ACS Appl Mater Interfaces; 2021 Feb; 13(7):8060-8070. PubMed ID: 33576220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer cell membrane-cloaked mesoporous silica nanoparticles with a pH-sensitive gatekeeper for cancer treatment.
    Liu CM; Chen GB; Chen HH; Zhang JB; Li HZ; Sheng MX; Weng WB; Guo SM
    Colloids Surf B Biointerfaces; 2019 Mar; 175():477-486. PubMed ID: 30572156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doxorubicin-loaded pH-sensitive micelles: A promising alternative to enhance antitumor activity and reduce toxicity.
    Cavalcante CH; Fernandes RS; de Oliveira Silva J; Ramos Oda CM; Leite EA; Cassali GD; Charlie-Silva I; Ventura Fernandes BH; Miranda Ferreira LA; de Barros ALB
    Biomed Pharmacother; 2021 Feb; 134():111076. PubMed ID: 33341054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.